MAY 13, 2020 3:33 PM PDT

Fecal Transplant Helps Fight off Antibiotic Resistance

WRITTEN BY: Annie Lennon

Fecal transplants work by transporting fecal matter from healthy donors to those who are less healthy. Now, a study has shown that the procedure may be able to help those with treatment-resistant bacterial infections. 

For the study, the researchers transferred fecal matter from healthy individuals to 20 patients infected with multi-drug resistant organisms. They then followed the patients for six months after the transplant and compared their prognosis to their symptoms six months prior. 

In the end, they found that fecal transplants managed to completely clear the resistant bacteria in 41% of the 17 patients who completed the follow-up. Although unable to completely clear the resistant bacteria in all patients, the researchers found that the procedure benefited these patients in other ways.

 "Many of these patients have had recurrent, prolonged courses of heavy-duty antibiotics, end-of-the-line treatments with high toxicity profiles, and repeated hospital stays. They had given up work or had family members forced to give up work to care for them - having a huge impact on quality of life," said Benjamin Mullish, a lead researcher of the study and clinical lecturer in the Division of Digestive Diseases, Imperial College London, England. 

"After this experimental treatment, we saw many in this group being able to go back to work, play with their grandkids and have an overall much better quality of life."

The researchers noted that all of the patients who completed the follow-up saw a reduction in bloodstream infections with resistant bacteria. Eight patients were even able to undergo stem-cell transplants within six months of the procedure without any adverse side effects. 

From their results, the researchers thus suggest that fecal transplants may be able to colonize resistant organisms. They also say that it may have a positive impact on other microbiota-related mechanisms, however to understand how these work, further study is required. 


Sources: EurekAlert, Reuters

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
MAY 02, 2022
Cell & Molecular Biology
Pipette Matchmaker: Tip Compatibility Like Never Before
MAY 02, 2022
Pipette Matchmaker: Tip Compatibility Like Never Before
Article Written by John Winsor All lab workers have to do it, shifting countless stacks of indiscernible boxes to f ...
APR 20, 2022
Drug Discovery & Development
Vitamin E Stimulates Dendritic Cells, Boosts Immunotherapy Effectiveness
APR 20, 2022
Vitamin E Stimulates Dendritic Cells, Boosts Immunotherapy Effectiveness
Dendritic cells play an important role in the immune system. Specifically, they help gather up antigen-presenting cells ...
MAY 06, 2022
Drug Discovery & Development
Scientists discover new methods of production for Sulphur-based medications
MAY 06, 2022
Scientists discover new methods of production for Sulphur-based medications
Modern medicine has drastically changed since humans discovered the first ancient treatment methods. Herbal remedies and ...
MAY 13, 2022
Drug Discovery & Development
Multiple Mental Health Diagnoses are Increasingly Common. Why?
MAY 13, 2022
Multiple Mental Health Diagnoses are Increasingly Common. Why?
Mental illness has become increasingly common. The number of people with anxiety and depression, specifically, has stead ...
MAY 19, 2022
Neuroscience
The Unconscious Brain at Work
MAY 19, 2022
The Unconscious Brain at Work
A study published in Neuron revealed how different cell types in the cerebral cortex change their activity during genera ...
JUN 09, 2022
Cancer
A Case Study May Identify a Novel Gene Therapy for Pancreatic Cancer
JUN 09, 2022
A Case Study May Identify a Novel Gene Therapy for Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is a very aggressive pancreatic cancer with limited treatment options.  PDA ...
Loading Comments...